Study of ARO-CFB in Adult Healthy Volunteers

NCT06209177 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

IgA Nephropathy

Interventions

DRUG: ARO-CFB
DRUG: Placebo

Sponsor

Arrowhead Pharmaceuticals